NCB Arrests Four, Seizes 34 Consignments of Psychotropic Drugs

Chandigarh, India Apr 12, 2021 ALN: The Narcotics Control Bureau (NCB) has made headlines recently with the arrest of four individuals and the seizure of 34 consignments of psychotropic drugs, notably Tramadol, during extensive searches conducted across Delhi, Uttar Pradesh, and Uttarakhand. The operation underscores the ongoing battle against drug trafficking in India, especially concerning substances that are not only abused domestically but also trafficked internationally, destined for countries such as the United States and various European nations.

Tramadol is a synthetic opioid that is commonly used as a pain suppressant, particularly for moderate to severe pain. However, its misuse has been linked to various criminal activities and has gained notoriety for its use among insurgent groups, including Islamic State fighters in Syria and various militant factions in Africa. This association highlights the global implications of drug trafficking, as the misuse of such substances can contribute to violence and instability in regions already facing significant challenges.

The NCB's recent operation revealed the extent of the drug trafficking module involved in the manufacturing, warehousing, and distribution of these psychotropic drugs. During the searches, the agency confiscated an astounding 30.50 lakh Tramadol tablets, alongside 70,000 bottles of codeine-based cough syrups and approximately 15 kilograms of amphetamine. The scale of these seizures illustrates the significant threat posed by such trafficking networks, which often exploit vulnerabilities in regulatory systems to operate undetected.

Details of the operation indicate that the drug trafficking module utilized the darknet to receive orders, which allowed them to maintain a level of anonymity and evade law enforcement detection. This method of operation is increasingly common among drug traffickers, as the darknet provides a platform for illicit transactions that are difficult to trace. The NCB intercepted several consignments during their investigation and discovered that the intermediaries involved were using fake identities while conducting their operations primarily from Delhi and its surrounding areas.

One of the key operators in this trafficking network, identified as K. Aggarwal, was tracked down in Agra, Uttar Pradesh. His arrest led to the apprehension of another individual, A. Goyal, also located in Agra. Further investigations revealed that the psychotropic drugs were being sourced from a pharmaceutical company based in Haridwar, which raises concerns about the integrity of pharmaceutical distribution channels in India. Subsequent searches at the company’s premises resulted in significant seizures, highlighting the potential complicity of legitimate businesses in the illegal drug trade.

This recent crackdown is not an isolated incident. The NCB had previously seized 56 lakh psychotropic medicines from Ghaziabad in Uttar Pradesh, leading to the arrest of four individuals in that case as well. The alleged mastermind of that operation, H. Singh, had obtained a distribution license under the name of one M. Yadav, who was reportedly compensated monthly for his involvement in the illicit activities. The drugs from that operation were being supplied to various states, including Punjab, Rajasthan, and Uttar Pradesh, indicating a widespread network of drug distribution that transcends regional boundaries.

“The syndicate is intricate and connected to various other groups,” stated NCB Deputy Director (Operations) K.P.S. Malhotra, emphasizing the complexity of the drug trafficking landscape in India. The involvement of multiple groups suggests that the issue of drug trafficking is not only a law enforcement challenge but also a public health crisis that requires coordinated efforts across different sectors.

The other two individuals arrested in the latest case were identified as Som Dutt and Manish. It is alleged that Som Dutt had connections with a previously arrested individual, Mausam, who was apprehended by the NCB last year. This connection highlights the continuity of operations within drug trafficking networks, where individuals often collaborate across different operations to maximize their reach and effectiveness. It is alleged that Som Dutt procured drugs from Manish and dispatched the consignments to international locations such as the United States and the United Kingdom, utilizing Indian Postal services based on forged documents. This method of shipping underscores the lengths to which traffickers will go to circumvent law enforcement efforts.

Psychotropic drugs like Tramadol fall under the category of synthetic opioids. They are used in the treatment of moderate to severe pain, but their potential for abuse is significant. The analgesic effect of Tramadol is multi-modal; it involves the release of serotonin and inhibits the reuptake of both noradrenaline and serotonin, which can lead to mood enhancement. This pharmacological profile makes Tramadol appealing not only for legitimate medical use but also for misuse and abuse, contributing to the opioid crisis that has affected many countries worldwide.

In response to the growing concerns surrounding the misuse of Tramadol and other psychotropic substances, India took the initiative to schedule Tramadol in 2018, thereby placing it under stricter regulatory controls. This decision reflects an acknowledgment of the challenges posed by synthetic opioids and the need for enhanced oversight in their distribution and use. However, the ongoing operations by the NCB indicate that despite regulatory measures, illegal trafficking persists, necessitating continual vigilance and proactive enforcement efforts.

The implications of these arrests and seizures extend beyond immediate law enforcement actions. They highlight the need for a comprehensive approach to address the root causes of drug trafficking, including public health initiatives aimed at reducing demand for such substances. Furthermore, the international nature of drug trafficking calls for enhanced cooperation among countries to combat the transnational networks that facilitate the movement of illegal drugs.

As the NCB continues its efforts to dismantle these trafficking networks, the situation serves as a reminder of the complexities involved in combating drug-related crimes. The interplay between legitimate pharmaceutical practices and illicit drug trafficking underscores the importance of regulatory oversight, public awareness, and international collaboration in addressing the multifaceted challenges posed by psychotropic drugs in today’s world.